Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Tester

Showing results (131-140 of 212) with videos related to

Pageof 22
Sort By:
Journal of Molecular and Cellular Cardiology|July 10, 2004
Characterization of a KCNQ1/KVLQT1 polymorphism in Asian families with LQT2: implications for genetic testingDipika Sharma, Kathryn A Glatter, V Timofeyev, et al.
Journal of Medical Genetics|March 8, 2017
KCNQ1 p.L353L affects splicing and modifies the phenotype in a founder population with long QT syndrome type 1Jamie D Kapplinger, Anders Erickson, Sirisha Asuri, et al.
Cardiovascular Research|September 28, 2007
A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardiaBi-Hua Tan, Pedro Iturralde-Torres, Argelia Medeiros-Domingo, et al.
Circulation. Genomic and Precision Medicine|July 21, 2022
Acacetin, a Potent Transient Outward Current Blocker, May Be a Novel Therapeutic for <i>KCND3</i>-Encoded Kv4.3 Gain-of-Function-Associated J-Wave SyndromesDan Ye, Wei Zhou, Samantha K Hamrick, et al.
Circulation. Genomic and Precision Medicine|March 14, 2020
Triadin Knockout Syndrome Is Absent in a Multi-Center Molecular Autopsy Cohort of Sudden Infant Death Syndrome and Sudden Unexplained Death in the Young and Is Extremely Rare in the General PopulationDaniel J Clemens, Belinda Gray, Richard D Bagnall, et al.
Circulation|January 28, 2021
Suppression-Replacement <i>KCNQ1</i> Gene Therapy for Type 1 Long QT SyndromeSteven M Dotzler, C S John Kim, William A C Gendron, et al.
Journal of Molecular and Cellular Cardiology|June 24, 2008
Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin CAndrew P Landstrom, Michelle S Parvatiyar, Jose R Pinto, et al.
Stem Cell Reports|May 10, 2023
Cellular and electrophysiological characterization of triadin knockout syndrome using induced pluripotent stem cell-derived cardiomyocytesDaniel J Clemens, Dan Ye, Lili Wang, et al.
Molecular Genetics and Metabolism|December 15, 2005
Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethoninJ Martijn Bos, Rainer N Poley, Melissa Ny, et al.
Circulation|January 25, 2006
Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanismCorey L Anderson, Brian P Delisle, Blake D Anson, et al.
Pageof 22

Showing results (131-140 of 212) with videos related to

Sort By:
Pageof 22
Journal of Molecular and Cellular Cardiology|July 10, 2004
Characterization of a KCNQ1/KVLQT1 polymorphism in Asian families with LQT2: implications for genetic testingDipika Sharma, Kathryn A Glatter, V Timofeyev, et al.
Journal of Medical Genetics|March 8, 2017
KCNQ1 p.L353L affects splicing and modifies the phenotype in a founder population with long QT syndrome type 1Jamie D Kapplinger, Anders Erickson, Sirisha Asuri, et al.
Cardiovascular Research|September 28, 2007
A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardiaBi-Hua Tan, Pedro Iturralde-Torres, Argelia Medeiros-Domingo, et al.
Circulation. Genomic and Precision Medicine|July 21, 2022
Acacetin, a Potent Transient Outward Current Blocker, May Be a Novel Therapeutic for <i>KCND3</i>-Encoded Kv4.3 Gain-of-Function-Associated J-Wave SyndromesDan Ye, Wei Zhou, Samantha K Hamrick, et al.
Circulation. Genomic and Precision Medicine|March 14, 2020
Triadin Knockout Syndrome Is Absent in a Multi-Center Molecular Autopsy Cohort of Sudden Infant Death Syndrome and Sudden Unexplained Death in the Young and Is Extremely Rare in the General PopulationDaniel J Clemens, Belinda Gray, Richard D Bagnall, et al.
Circulation|January 28, 2021
Suppression-Replacement <i>KCNQ1</i> Gene Therapy for Type 1 Long QT SyndromeSteven M Dotzler, C S John Kim, William A C Gendron, et al.
Journal of Molecular and Cellular Cardiology|June 24, 2008
Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin CAndrew P Landstrom, Michelle S Parvatiyar, Jose R Pinto, et al.
Stem Cell Reports|May 10, 2023
Cellular and electrophysiological characterization of triadin knockout syndrome using induced pluripotent stem cell-derived cardiomyocytesDaniel J Clemens, Dan Ye, Lili Wang, et al.
Molecular Genetics and Metabolism|December 15, 2005
Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethoninJ Martijn Bos, Rainer N Poley, Melissa Ny, et al.
Circulation|January 25, 2006
Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanismCorey L Anderson, Brian P Delisle, Blake D Anson, et al.
Pageof 22